drugset / Trial / NCT01985685

The Effect of Thiamine vs. Placebo on VO2 in Critical Illness

NCT01985685

Phase 2 Completed 66 enrolled Beth Israel Deaconess Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to determine the effect of thiamine therapy on oxygen consumption (VO2) in critically-ill patients. We will evaluate this by measuring VO2 before and after thiamine or placebo administration in patients admitted to the ICU and requiring mechanical ventilation. A secondary aim is to evaluate the effect of thiamine vs. placebo on the metabolic profile of the patients.

Timeline

Start
2013-10
Primary completion
2016-05
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Thiamine Other / unclassified 200 mg Intravenous

Indications